Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT07458763
Active, not recruiting Not applicable

Rapid Response Home Care as an Alternative to Acute Admission

NCT07458763 · tracked via the Priya Life Science Denmark tracker
Sponsor
Copenhagen University Hospital at Herlev
Phase
Not applicable
Started
2025-09-01
Last updated
2026-08-12

Condition(s) studied

Infection

Investigational drug(s) / intervention(s)

Admission avoidance Hospital at Home

Admission avoidance Hospital at Home: The intervention group is evaluated in their homes by a mobile rapid response team to determine whether they can be safely treated at home instead of being admitted to the hospital. If deemed suitable, the patient receives treatment at home.

Study summary

This single-center, randomized, unblinded quality-improvement study evaluates whether a structured home-based rapid response team (RRT) intervention can safely reduce total hospital days among adults referred to the emergency department with suspected infection. Patients referred from general practitioners or the regional medical helpline (1813) between 09:00 and 22:00 are randomized 1:1 using Zelen's design to either standard in-hospital evaluation or a home-based assessment pathway delivered by a mobile clinical response team.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 18 years or older * Referred with suspected infection * Patients must be able to provide informed consent * Category C or D transports (non-emergency patient transport) and self-transported patients Exclusion Criteria: * Category A and B transport (emergency and urgent patient transport) * Suspected meningitis * Suspected sepsis * Suspected tropical disease * Suspected other time-critical infection * Immunodeficiency * Ongoing treatment with immunosuppressive/immunomodulating/chemotherapy treatment

Primary outcome measure(s)

  • Days Alive Outside of Hospital — 30 days from inclusion
    Number of days alive outside of hospital 30 days after initial referral (time of inclusion), including days receiving treatment at home.

Trial sites (1)

FacilityCityRegionStatus
University Hospital of Copenhagen Herlev Herlev Denmark

More Copenhagen University Hospital at Herlev trials in Denmark

High Impact Training to Patients with Prostate Cancer and Bone Metastases Recruiting
Benefit of Spectral Information in Patients Suspected for Lung Cancer Recruiting
Danish Precocious Puberty Study - DAPP Study A National Cohort Study on Incidence and Etiologies for Precocious Puberty Starting soon
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospital Admission Recruiting
Molecularly Redefining Small Bowel Adenocarcinoma to Accelerate Precision Patient Care Recruiting

Other trials for the same condition

Automated Insulin Delivery Versus Daily Injections for Hospital Diabetes Care Starting soon
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospital Admission Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07458763 on ClinicalTrials.gov ↗ ← All trials in Denmark